Company profile for Valsynthese

PharmaCompass

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Related CompaniesRelated Companies

About

Valsynthese, a privately held CDMO, is a member of the SSE Group. Headquartered in Brig, Switzerland, it has a broad international reach. With over a century of experience in highly hazardous and energetic chemistry, it has the expertise to develop fine chemical projects and has established the capability to produce key chemical intermediates and APIs under GMP and ISO certification. Valsynthese is regarded as one of Europe's most experienced CDMO chemical producers. It offers a variety of projects, ranging from lab procedures to tonne-scale manufacturing. It supplies its customers with high-quality products at competitive prices.

CONTACT DETAILS

Click the arrow to open the dropdown

Events

Webinars & Exhibitions

cphi-worldwide-milan-70313.png

CPhI Worldwide, Milan

Contact Supplier

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/valsynthese-party-content-23575.pdf

    https://www.pharmacompass.com/pdf/party/content/valsynthese-party-content-35898.pdf

    https://www.pharmacompass.com/pdf/party/content/valsynthese-party-content-61577.pdf

    https://www.pharmacompass.com/pdf/party/content/valsynthese-party-content-14497.pdf

    https://www.pharmacompass.com/pdf/party/content/valsynthese-party-content-83829.pdf

    https://www.pharmacompass.com/pdf/party/content/valsynthese-party-content-1649139075.pdf

    https://www.pharmacompass.com/pdf/party/content/valsynthese-party-content-1649138024.pdf

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmtech.com/view/phosgene-at-valsynthese-an-atom-economic-reagent-that-demonstrates-exceptional-versatility

PHARMATECH
21 Mar 2024

https://www.valsynthese.ch/files/Press%20releases/press-release_grignard_def.pdf

PRESS RELEASE
23 Nov 2023
Nitroglycerin: from Danger to Care
Nitroglycerin: from Danger to Care

18 May 2023

// PHARMTECH

https://www.pharmtech.com/view/nitroglycerin-from-danger-to-care

PHARMTECH
18 May 2023

https://www.valsynthese.ch/files/Press%20releases/View%20of%20VALSYNTHESE,%20YOUR%20SERVICE%20PREMIUM%20PARTNER%20IN%20CDMO%20FIELD_October%202022.pdf

PRESS RELEASE
27 Oct 2022
Chemicals Knowledge Hub Valsynthese
Chemicals Knowledge Hub Valsynthese

29 Jul 2022

// PRESS RELEASE

https://www.valsynthese.ch/files/Press%20releases/CKH_June_July_2022_Valsynthese.pdf

PRESS RELEASE
29 Jul 2022

https://www.socma.org/max-lauwiner-appointed-head-of-fine-chemicals-unit-at-valsynthese-and-member-of-the-management-team/

SOCMA
05 Jul 2022

Services

Discover the service capabilities from this company

KEY SERVICES

read-more
read-more

TOP RANKED SUPPLIER FOR: